Chebulic Myrobalan and Reduced Cognitive Impairment

Doses used in studies

mg/day: 3,000 (median 3,000, IQR 3,000–3,000) — 1 study

Time to effect

Median: 4 weeks · IQR 4 weeks–4 weeks · Range 4 weeks–4 weeks — Reported in 1 of 1 study

1 of 1 paper

Evaluating the effect of black myrobalan on cognitive, positive, and negative symptoms in patients with chronic schizophrenia: A randomized, double-blind, placebo-controlled trial.

2021-11-23
RCT
Phytotherapy research : PTR 36(1)
- Mohammad Banazadeh
- Mitra Mehrabani
- Nabi Banazadeh
- Fatemeh Dabaghzadeh
- Farzad Shahabi

PubMed: 34814232
DOI: 10.1002/ptr.7340

5 Insights on

Reduced Cognitive Impairment

High evidence
Clinical

Cognitive impairments (SCIP) (p value .004), negative symptoms (PANSS subscale) (p value .017), and excitement/activity (PANSS subscale) (p value .003) were significantly improved in the black myrobalan group compared with the control group after 4 weeks.

Effect: Beneficial
Effect size: Small
Significant: Yes
Dose: 3000 mg/day (six 500 mg capsules in two divided doses)